CanSino looks for next growth shot in ‘life after Covid’ 「新冠紅利」曇花一現 康希諾另覓新跑道
The vaccine maker is back to square one as a brief windfall fueled by demand for its Covid vaccines rapidly fades 這家國產新冠疫苗主要供貨商，因疫情放緩導致「新冠紅利」消失，去年業績打回原形。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.